Rydapt

Indicated For

Acute myeloid leukemia, systemic mastocytosis

About This Medication

# Novartis Patient Assistance Foundation Patient Guide: How to Get Rydapt at Low or No Cost ## About This Program The **Novartis Patient Assistance Foundation (NPAF)** helps eligible patients access Rydapt (midostaurin) at reduced or no cost if they cannot afford their medication. Rydapt is a prescription medication used to treat certain types of cancer. If you have been prescribed Rydapt but are struggling with the cost, this program may be able to help you get your medication without financial hardship. ## About Rydapt (Midostaurin) Rydapt is a targeted cancer therapy medication manufactured by Novartis Pharmaceuticals Corporation. It is used to treat acute myeloid leukemia (AML) and certain other blood cancers. Because Rydapt is a specialty medication, it can be expensive, which is why the NPAF program exists—to ensure that cost does not prevent patients from accessing the treatment their doctors have prescribed. ## Who Qualifies for NPAF? To be eligible for the Novartis Patient Assistance Foundation program, you must meet ALL of the following requirements: - **U.S. Residency**: You must be a resident of the United States or its territories - **Valid Prescription**: You must have a current, valid prescription for Rydapt from a licensed U.S. healthcare provider - **Outpatient Status**: You must be receiving treatment on an outpatient basis (not hospitalized) - **Insurance Status**: You must have limited or no prescription drug coverage. This includes patients who: - Have no insurance at all - Have insurance but cannot afford the medication even with coverage - Are uninsured or underinsured for prescription drugs - **Income Requirements**: Your household income must meet NPAF's sliding scale requirements based on the Federal Poverty Level (FPL) ## Income Eligibility NPAF uses a sliding scale income requirement that varies based on your household size and is set at or below **400% of the Federal Poverty Level (FPL)**. This means the income limit increases as your household size increases. The specific income thresholds for your household size can be found on the NPAF website at **pap.novartis.com**. Because income limits vary by product and household composition, you should verify your eligibility directly through their website or by calling their support line. **Example Income Ranges (2024 Federal Poverty Guidelines at 400% FPL)**: | Household Size | Approximate Maximum Annual Income | |---|---| | 1 person | ~$55,000 | | 2 people | ~$74,000 | | 3 people | ~$93,000 | | 4 people | ~$112,000 | *Note: These are approximate figures based on 400% FPL. Actual limits may vary and should be confirmed with NPAF.* ## Insurance Requirements The NPAF program is designed for patients with **limited or no prescription drug coverage**. This includes: - Patients with no health insurance - Patients with health insurance but no prescription drug coverage - Patients whose insurance does not cover Rydapt - Patients who cannot afford their medication despite having insurance If you have Medicare, Medicaid, or other public or private insurance, you may still qualify if your coverage does not include Rydapt or if you cannot afford the out-of-pocket costs. You will need to provide copies of your insurance cards (front and back) as part of your application. ## How to Apply: Step-by-Step Instructions ### Step 1: Check Your Eligibility Visit **pap.novartis.com** to review the detailed eligibility requirements for Rydapt. You can also call the NPAF support team at **1-800-277-2254** to discuss your situation and confirm you may qualify. ### Step 2: Gather Required Documentation Before starting your application, collect the following documents: - **Proof of Income**: One of the following: - Copy of your most recent year's federal tax return (first two pages) - 3 months of recent paycheck stubs - 3 months of recent bank statements - Unemployment benefit statements (if applicable) - **Insurance Information**: Copies of the front and back of ALL insurance cards (primary, secondary, and prescription insurance) - **Valid Prescription**: Your healthcare provider will need to provide this as part of their section - **Proof of Residency**: Documentation showing you are a U.S. resident (may be included in tax return or other documents) **Important**: Do not send original documents. Submit copies only. ### Step 3: Complete the Patient Section Fill out the patient application form available at **pap.novartis.com**. The form requires: - Your personal information (name, date of birth, contact information) - Household size (number of people living in your home) - Insurance information - Income information - Authorization for NPAF to contact your healthcare providers and pharmacies - Your signature and date Make sure all fields are completed accurately. Incomplete applications will delay processing or result in denial. ### Step 4: Have Your Healthcare Provider Complete Their Section Your prescribing physician or their office must: - Complete the healthcare provider section of the application - Provide a valid prescription for Rydapt - Sign and date the form - If required by your insurance, include any Prior Authorization (PA) denial documentation Your healthcare provider's office can fax or mail the form directly, or you can submit it together with your patient section. ### Step 5: Submit Your Application Submit your completed application with all supporting documents using ONE of these methods: **By Mail**: Novartis Patient Assistance Foundation, Inc. P.O. Box 2529 Columbus, OH 43216 **By Fax**: 1-855-817-2711 *Note: If faxing, the application must be sent from your healthcare provider's office.* ### Step 6: Receive Your Decision You will receive a decision letter within approximately **4 weeks** of submitting your complete application. If your application is incomplete, you will receive a letter explaining what additional information is needed. ## Timeline and Medication Delivery - **Application Processing**: Approximately 2-4 weeks from the date you submit a complete application - **Medication Delivery**: Once approved, your Rydapt will be shipped directly to you or your healthcare provider - **Ongoing Support**: You will receive your medication as long as you remain eligible and reauthorize annually ## What If Your Application Is Denied? If your application is denied, the decision letter will explain the reason. Common reasons for denial include: - Income exceeds the program's limits - You have adequate prescription drug coverage - Incomplete or inaccurate application - Not meeting residency requirements If you believe your application was denied in error, or if your circumstances have changed, you can: - Call NPAF at **1-800-277-2254** to discuss your situation - Reapply if your income or insurance status has changed - Ask about alternative assistance programs that may be available ## Reauthorization and Ongoing Eligibility NPAF requires **annual reauthorization** to continue receiving assistance. You will need to: - Provide updated income documentation - Confirm your insurance status has not changed - Notify NPAF immediately if your income or health coverage changes during the year If your circumstances change, call NPAF at **1-800-277-2254** to update your information. ## Questions and Support For questions about the application process, eligibility, or your status: **Phone**: 1-800-277-2254 **Website**: pap.novartis.com **Fax**: 1-855-817-2711 NPAF representatives are available to answer your questions and help guide you through the application process. ## Important Disclaimer This guide provides general information about the Novartis Patient Assistance Foundation program. Program eligibility, requirements, and benefits may change at any time at Novartis's sole discretion. The information in this guide is current as of the date of publication but should be verified with NPAF directly at pap.novartis.com or by calling 1-800-277-2254. This guide is not a guarantee of program eligibility or approval. Only the official NPAF application and eligibility determination constitute a binding agreement. Always consult with your healthcare provider about your treatment options and financial assistance programs.

Program information last verified: March 25, 2026